Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06835504 · ClinicalTrials.gov registry record · Phase 3
Morphine or Ketamine for Analgesia
A Phase 3 study, sponsored by Columbia University.
- Not yet
- Registry status
- Phase 3
- Development phase
- 1,010
- Enrollment target
NCT06835504 is a Phase 3 study that has not yet begun recruiting, run by Columbia University. The registered enrollment target is 1,010 participants.
The verdict
NCT06835504, a Phase 3 study, has not yet begun recruiting, sponsored by Columbia University.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 1,010 participants
- Enrollment target
Study Summary
Pain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine is the standard treatment for children with moderate to severe acute pain, but its use is associated with serious side effects and caregiver and clinician concerns related to opioid administration. The investigators aim to determine if sub-dissociative ketamine is non-inferior to morphine for treating acute pain and a preferable alternative for treating acute pain in children because of its more favorable side effect profile and potential long-term benefits related to pain-related function, analgesic use/misuse, and mental and behavioral health outcomes.
Interventions
- DRUG Ketamine hydrochloride
- DRUG Morphine sulphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,010 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2030-02-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06835504
The ClinicalTrials.gov registry entry for NCT06835504 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 1,010 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine hydrochloride is the first listed.
NCT06835504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06835504 about?
NCT06835504 is a clinical study titled "Morphine or Ketamine for Analgesia". Pain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine is the standard treatment for children with moderate to severe acute pain, but its use is associated with serious side effects and caregiver a...
What is the current status of trial NCT06835504?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 1,010 participants. The study started on 2026-09-01. Estimated completion is 2030-02-28.
What interventions are being tested in trial NCT06835504?
The interventions under investigation include: Ketamine hydrochloride (DRUG), Morphine sulphate (DRUG).
Who is sponsoring clinical trial NCT06835504?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.